VI Partners is a venture capital and private equity firm investing in healthcare, biotechnology, and software companies.
VI Partners typically invests in early- and growth-stage biotechnology, healthcare, and software companies. As of November 2019, the firm has made nintey-one investments, has twenty-four companies in its portfolio, and has made twenty-nine exits. Notable investments made by VI Partners include Avalon Photonics, Deal United, EpiSpeed, Hybris Software, Mesa Imaging, Mila, Nexthink, PicoDRILL, Visonys, Activaero, Endoart Medical Technologies, Endo Sense, Neocutis, Neogym, Oncalis, Spinelab, Thommen Medical, Xigen, Edimer, Kuros BiosciencesKuros Biosciences, Ventaleon, Gamaya, Ledgy, Myotest, Senbiosys, Sonic Emotion, and Smart Valor.
VI Partners is a venture capital and private equity firmprivate equity firm investing in healthcare, biotechnology, and software companies. The firm is headquartered in Altendorf, Switzerland and was founded in 2001 by Alain Nicod, Arnd Kaltofen, Daniel Gutenberg, and Diego Braguglia. The firm took over the advisory of the Venture Incubator Fund when the company was founded in 2001. The Venture Incubator Fund was created in 2000 by its two strategic partners, McKinsey & Company and the Swiss Federal Institute of Technology in Zurich (ETHZ). The purpose of the fund is to support startup companies based in Switzerland. Shareholders of the Venture Incubator Fund are ABB, Sulzer, Schindler, Hilti, Zurcher Kantonalbank, Suva, Buhler, Novartis, Credit Suisse, and Nestle.
VPVI Partners is a venture capital and private equity firm investing in healthcare, biotechnology, and software companies.
AVP Partners is a venture capital and private equity firm investing in healthcare, biotechnology, and software companies.
VI Partners is a venture capital and private equity firm investing in healthcare, biotechnology, and software companies. thatThe firm is headquartered in Altendorf, Switzerland and was founded in 2001 by Alain Nicod, Arnd Kaltofen, Daniel Gutenberg, and Diego Braguglia. The firm took over the advisory of the Venture Incubator Fund when the company was founded in 2001. The Venture Incubator Fund was created in 2000 by its two strategic partners, McKinsey & Company and the Swiss Federal Institute of Technology in Zurich (ETHZ). The purpose of the fund is to support startup companies based in Switzerland. Shareholders of the Venture Incubator Fund are ABB, Sulzer, Schindler, Hilti, Zurcher Kantonalbank, Suva, Buhler, Novartis, Credit Suisse, and Nestle.
VI Partners typically invests in earlyearly- and growth-stage biotechnology, healthcare, and software companies. As of November 2019, the firm has made 91nintey-one investments, has 24twenty-four companies in its portfolio, and has made 29twenty-nine exits. Notable investments made by VI Partners include: Avalon Photonics, Deal United, EpiSpeed, Hybris Software, Mesa Imaging, Mila, Nexthink, PicoDRILL, Visonys, Activaero, Endoart Medical Technologies, Endo Sense, Neocutis, Neogym, Oncalis, Spinelab, Thommen Medical, Xigen, Edimer, Kuros Biosciences, Ventaleon, Gamaya, Ledgy, Myotest, Senbiosys, Sonic Emotion, and Smart Valor.
November 19, 2021
November 19, 2021
May 18, 2020